Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Prostate International|January 11, 2021
Biparametric versus multiparametric magnetic resonance imaging of the prostate: detection of clinically significant cancer in a perfect match groupJungheum Cho, Hyungwoo Ahn, Sung Il Hwang, et al.
Prostate International|October 13, 2022
Diagnostic yield of multiparametric MRI for local recurrence at biochemical recurrence after radical prostatectomyMinsu Kim, Sung Il Hwang, Hyungwoo Ahn, et al.
Abdominal Radiology (New York)|October 13, 2023
MR imaging findings of ovarian lymphoma: differentiation from other solid ovarian tumorsTaek Min Kim, Hyungwoo Ahn, Sang Youn Kim, et al.
Abdominal Radiology (New York)|June 13, 2022
Differentiating renal epithelioid angiomyolipoma from clear cell carcinoma: using a radiomics model combined with CT imaging characteristicsTaek Min Kim, Hyungwoo Ahn, Hyo Jeong Lee, et al.
Korean Journal of Radiology|March 10, 2018
Multimodality Imaging in Patients with Secondary Hypertension: With a Focus on Appropriate Imaging Approaches Depending on the EtiologiesHyungwoo Ahn, Eun Ju Chun, Hak Jong Lee, et al.
Prostate Cancer and Prostatic Diseases|June 1, 2022
Diagnostic value of multiparametric MRI in detecting residual or recurrent prostate cancer after high-intensity focused ultrasoundHyungwoo Ahn, Sung Il Hwang, Taek Min Kim, et al.
European Radiology|September 5, 2020
Quantitation of bladder cancer for the prediction of muscle layer invasion as a complement to the vesical imaging-reporting and data systemHyungwoo Ahn, Sung Il Hwang, Hak Jong Lee, et al.
European Radiology|July 12, 2023
Tumor contact length with bladder wall provides effective risk stratification for lesions with a VIRADS score of 2-3Hyungwoo Ahn, Taek Min Kim, Sung Il Hwang, et al.
European Radiology|August 7, 2019
Prediction of extraprostatic extension on multi-parametric magnetic resonance imaging in patients with anterior prostate cancerHyungwoo Ahn, Sung Il Hwang, Hak Jong Lee, et al.
BMC Urology|April 6, 2021
Favorable intermediate risk prostate cancer with biopsy Gleason score of 6Jong Jin Oh, Hyungwoo Ahn, Sung Il Hwang, et al.
Pageof 4